Abstract |
Although the efficacy of ceftriaxone in typhoid fever is well documented, the precise duration of ceftriaxone therapy in children with typhoid fever is not established and varies from 3 to 14 days in the literature. In a prospective, randomized study ceftriaxone was compared with chloramphenicol for treatment of 72 children who had bacteriologically confirmed typhoid fever. Ceftriaxone was given at a dose of 75 mg/kg per day (maximally 2 g/day) intravenously, in two doses until defervescence and continued 5 days after that time. Chloramphenicol was given at a dose of 75 mg/kg per day (maximally 2 g/day) in four doses for 14 days. Mean defervescence time was in 5.4 days in the ceftriaxone group and 4.2 days in the chloramphenicol group (P=0.04). Clinical cure without complications was achieved in all patients in both groups. No patient relapsed in the ceftriaxone group, and four patients relapsed in the chloramphenicol group (P=0.048). The overall results of this study suggest that a flexible-duration of ceftriaxone therapy given until defervescence time, followed by an additional 5 days of therapy is a reasonable alternative to conventional 14-day chloramphenicol treatment in children with typhoid fever.
|
Authors | Mustafa Mansur Tatli, Guler Aktas, Mustafa Kosecik, Abdulkadir Yilmaz |
Journal | International journal of antimicrobial agents
(Int J Antimicrob Agents)
Vol. 21
Issue 4
Pg. 350-3
(Apr 2003)
ISSN: 0924-8579 [Print] Netherlands |
PMID | 12672582
(Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Chloramphenicol
- Ceftriaxone
|
Topics |
- Adolescent
- Anti-Bacterial Agents
(therapeutic use)
- Ceftriaxone
(therapeutic use)
- Child
- Child, Preschool
- Chloramphenicol
(therapeutic use)
- Drug Administration Schedule
- Female
- Humans
- Male
- Prospective Studies
- Randomized Controlled Trials as Topic
- Typhoid Fever
(blood, drug therapy)
|